TTC7

TTC7 refers to the tetratricopeptide repeat domain 7 protein family, which is encoded by two closely related human genes, TTC7A and TTC7B. The proteins contain multiple tetratricopeptide repeat motifs that mediate protein–protein interactions. TTC7A and TTC7B are expressed in a variety of tissues, with highest expression in the gut, liver, lung, and immune organs. They are thought to act as scaffolding components in signaling complexes and to regulate phospholipid signaling pathways, particularly through interactions with phosphatidylinositol transfer proteins. TTC7 proteins have been shown to recruit the membrane phosphatidylinositol-4-phosphate 5-kinase to cellular membranes, thereby influencing the production of phosphatidylinositol 4,5-bisphosphate, a key regulator of membrane trafficking and cytoskeletal dynamics.

Mutations in TTC7A are linked to combined immunodeficiency and intestinal disease. Patients with loss‑of‑function variants present with early‑onset severe diarrhea, small‑bowel atresia, and congenital enteropathies characterized by short‑bile-tract and gut malabsorption. Neurological manifestations such as microcephaly and peripheral neuropathy have also been reported. Mutations in TTC7B correlate with late‑onset inflammatory bowel disease resembling Crohn’s disease and, less frequently, with immunological abnormalities, suggesting a role in intestinal epithelial integrity and mucosal immune responses.

The biochemical pathways involving TTC7 are still being mapped. Studies show that TTC7A deficiency compromises the integrity of the pyloric sphincter, leading to structural failure and increased intestinal permeability. In vitro knockdown experiments indicate that TTC7A participates in the regulation of autophagy and apoptotic signaling in intestinal epithelial cells. Because of the clinical heterogeneity, genetic testing for TTC7A and TTC7B variants is recommended in patients with unexplained congenital diarrhea and immune deficiency, and prenatal screening may be considered in families with a known pathogenic mutation.

Research into TTC7 function continues to uncover its relevance to digestive physiology, immune regulation, and disease susceptibility. As additional genetic variants are identified, the understanding of TTC7-associated disorders is expected to expand, guiding targeted therapeutic strategies and improving patient outcomes.